Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-25-000318
Filing Date
2025-06-13
Accepted
2025-06-13 17:07:11
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5986
  Complete submission text file 0000904454-25-000318.txt   7455
Mailing Address C/O CG ONCOLOGY, INC. 400 SPECTRUM DRIVE SUITE 2040 IRVINE CA 92618
Business Address
POST LEONARD E (Reporting) CIK: 0001235862 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 251047605

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)